[ARWR] QoQ Quarter Result on 30-Sep-2021 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
22-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q4]
Profit Trend
QoQ- -111.78%
YoY- -30.85%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 32,412 151,805 27,439 38,283 45,891 32,811 21,303 32.38%
PBT -72,046 44,366 -62,872 -63,372 -29,924 -26,818 -20,732 129.95%
Tax -863 -2,813 -1,156 2 -1,280 -1,524 -2,169 -45.99%
NP -71,183 44,366 -62,872 -63,374 -29,924 -26,818 -20,732 128.10%
Tax Rate - 6.34% - - - - - -
Total Cost 103,595 107,439 90,311 101,657 75,815 59,629 42,035 82.75%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -219.62 29.23 -229.13 -165.54 -65.21 -81.73 -97.32 72.30%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.67 0.42 -0.60 -0.61 -0.29 -0.26 -0.20 124.38%
EPS Diluted -0.67 0.41 -0.60 -0.61 -0.29 -0.26 -0.20 124.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.